Business
Comment on mouthwash & COVID-19 transmission
Comment on mouthwash & COVID-19 transmission.
About this update from Venture Life Group Plc
[{"type":"text","content":"\n \n \n RNS Number : 9853M\n Venture Life Group PLC\n 15 May 2020\n \n \n \n \n 15 May 2020\n \n \n VENTURE LIFE GROUP PLC\n \n \n (\"Venture Life\" \"VLG\" or the \"Group\")\n \n \n Comment re mouthwash study into potential reduction of COVID-19 transmission \n \n \n Venture Life (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, notes the research published yesterday in the journal Function, which supports the idea that using mouthwash should be considered as a way to reduce transmission of enveloped viruses such as COVID-19. A link to the research can be found at the bottom of this announcement.\n \n \n \n \n \n The study, which was led by Cardiff University's Systems Immunity Research Institute and was covered widely by media outlets, is backed by virologists, lipid specialists and healthcare experts from the universities of Nottingham, Barcelona and Cambridge's Babraham Institute. The findings made reference to mouthwashes containing, among other things, cetylpyridinium chloride (CPC), which is the main ingredient in Venture Life's key mouthwash brand - Dentyl Dual Action. Dentyl has been in the UK market for more than 25 years and is widely available, including both the UK and China. At this stage, there can be no certainty that mouthwashes containing CPC will be effective in combatting COVID-19 or indeed that there will be any impact on trading for the Company. However, the study recommended further research in this area and this is fully supported by Venture Life and others. Further detail on Dentyl can be found in the Company's annual results, which were announced on 9 April 2020.\n \n \n \n \n \n Lead author of the study, Professor Valerie O'Donnell, co-director of Cardiff University's Systems Immunity Research Institute, said \"Our review of the literature suggests that research is needed as a matter or urgency to determine its potential for use against this new virus\".\n \n \n \n \n \n \n Jerry Randall, CEO of Venture Life, commented:\n \n \"The research findings published yesterday were very interesting and we fully support the need for more research into whether existing mouthwashes on the market, such as those containing CPC, as Dentyl does, could help to slow the transmission of COVID-19. Venture Life will make eve...